It is the final day of Phase 1 Programming and The Sediment sets sail with the SHIP-AHOY study discussion with Dr. Don Batisky, Dr. Tammy Brady and Dr. Andrew South. We ponder over obesity associated hypertension, renovascular hypertension and ABPM as a “gold standard” and what it all means for our most vulnerable patients. Dr. Stephanie Jernigan recaps the Vasculitis session talks and we get excited about Bemulimumab and Voclosporin (just not about their spelling) and we discuss ADVOCATE trial results. Dr. Shatat joins us to talk about social media at ASPN, Dr. Maury Pinsk returns to tell us about Phase 2 and yes- we congratulate the winners of the research and clinical awards, Barnett awardees (2020 &2021) and a special mentor award for Dr. Furth. The panelists also named their favorite drinks but that will have to be in a different podcast!
See you all in Denver, folks!
